"Who We Are Four Rivers Clinical Research, Inc. was founded in 1994. Our mission is to perform state of the art clinical research with the highest levels of excellence and integrity. In doing so, we will contribute to the development of novel, safe, and effective therapies which will advance the quality of patient care in our region and beyond."

During the past decade, Four Rivers Clinical Research Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 19 clinical trials were completed, i.e. on average, 211.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Four Rivers Clinical Research Inc." #1 sponsor was "Shire" with 10 trials, followed by "Pfizer" with 6 trials sponsored, "Cephalon" with 4 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "AEterna Zentaris" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Four Rivers Clinical Research Inc." #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Cardiokine Biopharma, LLC" with 2 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Eisai Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Four Rivers Clinical Research Inc." are "Alzheimer's Disease" (10 trials), "ADHD" (5 trials), "Attention-Deficit/Hyperactivity Disorder" (4 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Four Rivers Clinical Research Inc." in a lesser frequency.

Most popular intervention types in "Four Rivers Clinical Research Inc." are "Drug" (53 trials), "Device" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "placebo" (3 trials), "AVP-786" (2 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Four Rivers Clinical Research Inc." are 53 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Four Rivers Clinical Research Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Four Rivers Clinical Research Inc., undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Four Rivers Clinical Research Inc., 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".